Your browser doesn't support javascript.
Interleukin-17 inhibitor, is it safer than tumor necrosis factor inhibitor?
Huang, Jinxian; Zhang, Lijun; Wei, James C-C.
  • Huang J; Division of Rheumatology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Zhang L; Division of Rheumatology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Wei JC; Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
Int J Rheum Dis ; 24(7): 865-868, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1343800

Full text: Available Collection: International databases Database: MEDLINE Main subject: Osteoarthritis / Arthritis / Interleukin-17 / Tumor Necrosis Factor Inhibitors Limits: Humans Language: English Journal: Int J Rheum Dis Journal subject: Rheumatology Year: 2021 Document Type: Article Affiliation country: 1756-185X.14076

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Osteoarthritis / Arthritis / Interleukin-17 / Tumor Necrosis Factor Inhibitors Limits: Humans Language: English Journal: Int J Rheum Dis Journal subject: Rheumatology Year: 2021 Document Type: Article Affiliation country: 1756-185X.14076